New Trials and Therapies for Acute Myocardial Infarction

Richard J. Gumina

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Acute coronary syndromes (ACSs), which include the clinical entities of unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), account for more than 1.5 million hospital admissions annually in the United States alone. Approximately 1 million of these admissions are classified as UA/NSTEMI and approximately 500,000 are STEMI. Because of the overwhelming number of studies on ACSs over the past several years, this article focuses on new trials and therapies for treating patients diagnosed with STEMI.

Original languageEnglish (US)
Pages (from-to)729-749
Number of pages21
JournalMedical Clinics of North America
Issue number4
StatePublished - Jul 2007
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'New Trials and Therapies for Acute Myocardial Infarction'. Together they form a unique fingerprint.

Cite this